Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1999

Primary Completion Date

October 31, 2001

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carboplatin

DRUG

irinotecan hydrochloride

RADIATION

radiation therapy

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00010036 - Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter